An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Fredman, Gabrielle, Hellmann, Jason, Proto, Jonathan D., Kuriakose, George, Colas, Romain A., Dorweiler, Bernhard, Connolly, E. Sander, Solomon, Robert +4 more·2016·Nature Communications
DOI 10.1038/ncomms12859

Cited by (412)

Items 101–200 of 412

  1. Resolution Pharmacology: Focus on Pro-Resolving Annexin A1 and Lipid Mediators for Therapeutic Innovation in Inflammation
    Mauro Perretti, Jesmond Dalli · 2022 · The Annual Review of Pharmacology and Toxicology
  2. Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes
    Valerio Chiurchiù, Alessandro Leuti, Stefano Saracini, Davide Onofrio Fontana, Panaiotis Finamore, Renato Giua, Lucia Padovini, Raffaele Antonelli Incalzi, Mauro Maccarrone · 2018 · The FASEB Journal
  3. PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function
    Kimberly Pistorius, Patricia R. Souza, Roberta De Matteis, Shani Austin‐Williams, Karoline Gangestad Primdahl, Anders Vik, Francesca Mazzacuva, Romain Alexandre Colas, Raquel M. Marques, Trond Vidar Hansen et al. · 2018 · Cell chemical biology
  4. Lipoxin Mimetics and the Resolution of Inflammation
    Catherine Godson, Patrick J. Guiry, Eoin Patrick Brennan · 2023 · The Annual Review of Pharmacology and Toxicology
  5. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
    Antonio Recchiuti, Domenico Mattoscio, Elisa Isopi · 2019 · Frontiers in Pharmacology
  6. Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid + resolvin E1) to leukotriene B 4
    Francine K. Welty, Fabian Schulte, Abdulhamied Alfaddagh, Tarec K. Elajami, Bruce Ryan Bistrian, Markus Hardt · 2021 · The FASEB Journal
  7. Sex Differences in Pulmonary Eicosanoids and Specialized Pro-Resolving Mediators in Response to Ozone Exposure
    Michael J. Yaeger, Sky W. Reece, Brita J. Kilburg-Basnyat, Miles X Hodge, Anandita Pal, Katelyn Dunigan, Bin Luo, Dorothy J. You, James C. Bonner, Espen E. Spangenburg et al. · 2021 · Toxicological Sciences
  8. Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development
    Kabir Ahluwalia, Brandon Ebright, Kingsley V. Chow, Priyal Dave, Andrew Mead, Roy A. Poblete, Stan G. Louie, Isaac Asante · 2022 · Metabolites
  9. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins
    James A. Hamilton, Hatice Hastürk, Alpdoğan Kantarcı, Charles Nicholas Serhan, Thomas E. Van Dyke · 2017 · Current Atherosclerosis Reports
  10. Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration
    Aaron H. Wasserman, Manigandan Venkatesan, Aitor Aguirre · 2020 · Cells
  11. Biosynthesis of proresolving lipid mediators by vascular cells and tissues
    Anuran Chatterjee, Sevan R. Komshian, Brian E. Sansbury, Bian Wu, Giorgio Mottola, Mian Chen, Matthew R. Spite, Michael S. Conte · 2017 · The FASEB Journal
  12. Myeloid ALX/FPR2 regulates vascularization following tissue injury
    Brian E. Sansbury, Xiaofeng Li, Blenda Chi Kwan Wong, Andreas Patsalos, Nikolas Giannakis, Michael J. Zhang, László Nagy, Matthew R. Spite · 2020 · Proceedings of the National Academy of Sciences
  13. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect
    Gabrielle Fredman, Katherine C. MacNamara · 2021 · Cardiovascular Research
  14. Sources of 7-ketocholesterol, metabolism and inactivation strategies: food and biomedical applications
    Imen Ghzaiel, Khouloud Sassi, Amira Zarrouk, Shubhrima Ghosh, Irundika H.K. Dias, Thomas Nury, Mohamed Ksila, Soukaina Essadek, Mounia Tahri-Joutey, Fatiha Brahmi et al. · 2022 · Redox Experimental Medicine
  15. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications
    Mariarosaria Valente, Marta Dentoni, Fabrizio Bellizzi, Fedra Kuris, Gian Luigi Gigli · 2022 · Molecules
  16. Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration
    Charles Nicholas Serhan, Nan Chiang · 2023 · Prostaglandins & Other Lipid Mediators
  17. AT-RVD1 repairs mouse lung after cigarette smoke-induced emphysema via downregulation of oxidative stress by NRF2/KEAP1 pathway
    Sara Vergel Posso, Nicolas Quesnot, João Alfredo Moraes, Lycia de Brito‐Gitirana, Emanuel Kennedy-Feitosa, Marina Valente Barroso, Luís Cristóvão Pôrto, Manuella Lanzetti, Samuel Santos Valença · 2018 · International Immunopharmacology
  18. ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution
    Arif Yurdagul, Na Kong, Brennan D. Gerlach, Xiaobo Wang, Patrick B. Ampomah, George Kuriakose, Wei Tao, Jinjun Shi, Ira A. Tabas · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
  19. Deficiency of macrophage PHACTR1 impairs efferocytosis and promotes atherosclerotic plaque necrosis
    Canan Kasikara, Maaike Schilperoort, Brennan D. Gerlach, Chenyi Xue, Xiaobo Wang, Ze Zheng, George Kuriakose, Bernhard Dorweiler, Hanrui Zhang, Gabrielle Fredman et al. · 2021 · Journal of Clinical Investigation
  20. Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases
    Rafael I. Jaén, Sergio Sánchez‐García, María Fernández‐Velasco, Lisardo Boscá, Patricia Prieto · 2021 · Frontiers in Immunology
  21. Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease
    Hernan A. Bazán, Yan Lu, Bokkyoo Jun, Zhide Fang, T. Cooper Woods, Song Hong · 2017 · Prostaglandins Leukotrienes and Essential Fatty Acids
  22. Pro-resolving lipid mediators: Agents of anti-ageing?
    Ross Doyle, Denise M. Sadlier, Catherine Godson · 2018 · Seminars in Immunology
  23. Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
    María Paz Beyer, Luis Alberto Videla, Camila Farías, Rodrigo Valenzuela · 2023 · Nutrients
  24. Frontline Science: A reduction in DHA-derived mediators in male obesity contributes toward defects in select B cell subsets and circulating antibody
    Miranda J. Crouch, Rasagna Kosaraju, William Guesdon, Michael Armstrong, Nichole A. Reisdorph, Raghav Jain, Jenifer I. Fenton, Saame Raza Shaikh · 2018 · Journal of Leukocyte Biology
  25. Radiation-Induced Macrophage Senescence Impairs Resolution Programs and Drives Cardiovascular Inflammation
    Sudeshna Sadhu, Christa Decker, Brian E. Sansbury, Michael Marinello, Allison N. Seyfried, Jennifer E. Howard, Masayuki Mori, Zeinab Hosseini, Thilaka Arunachalam, Aloke Virmani Finn et al. · 2021 · The Journal of Immunology
  26. New maresin conjugates in tissue regeneration pathway counters leukotriene D 4 –stimulated vascular responses
    Nan Chiang, Ian R. Riley, Jesmond Dalli, Ana R. Rodrı́guez, Bernd Werner Spur, Charles Nicholas Serhan · 2018 · The FASEB Journal
  27. Distinct Profiles of Specialized Pro-resolving Lipid Mediators and Corresponding Receptor Gene Expression in Periodontal Inflammation
    Brittney Ferguson, Nishantha R. Bokka, Krishna Rao Maddipati, Srinivas Ayilavarapu, Robin L. Weltman, Lisha Zhu, Wanqi Chen, Wenjin Jim Zheng, Nikola Angelov, Thomas E. Van Dyke et al. · 2020 · Frontiers in Immunology
  28. Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders
    Jinjie Duan, Yayue Song, Xu Zhang, Chunjiong Wang · 2021 · Frontiers in Physiology
  29. Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins
    Sajjad Chamani, Vanessa Bianconi, Aida Tasbandi, Matteo Pirro, George Emilio Barreto, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2020 · Mediators of Inflammation
  30. Arachidonic Acid Metabolites in Neurologic Disorders
    Oğuzhan Kurşun, Hülya Karataş, Hülagu Barışkaner, Şerefnur Öztürk · 2021 · CNS & Neurological Disorders - Drug Targets
  31. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension
    Lucía Serrano Díaz del Campo, Ana B. García‐Redondo, Cristina Rodrı́guez, Carlos Zaragoza, Santiago Duro‐Sánchez, Francesco Palmas, Ángela de Benito-Bueno, Paula G. Socuéllamos, Diego Alberto Peraza, Raquel Rodrigues‐Díez et al. · 2022 · Hypertension
  32. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model
    Bian Wu, Evan C. Werlin, Mian Chen, Giorgio Mottola, Anuran Chatterjee, Kevin D. Lance, Daniel A. Bernards, Brian E. Sansbury, Matthew R. Spite, Tejal Ashwin Desai et al. · 2018 · Journal of Vascular Surgery
  33. Omega-3 fatty acid intake suppresses induction of diverse autoantibody repertoire by crystalline silica in lupus-prone mice
    Lichchavi Dhananjaya Rajasinghe, Quan‐Zhen Li, Chengsong Zhu, Mei Yan, Preeti Chauhan, Kathryn A. Wierenga, Melissa A. Bates, Jack R. Harkema, Abby D. Benninghoff, James J. Pestka · 2020 · Autoimmunity
  34. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases
    Luíza Oliveira Perucci, Michelle A. Sugimoto, Karina Braga Gomes, Luci Maria Sant’Ana Dusse, Mauro Martins Teixeira, Lirlandia Pires Sousa · 2017 · Expert Opinion on Therapeutic Targets
  35. Long-Term Engraftment Promotes Differentiation of Alveolar Epithelial Cells from Human Embryonic Stem Cell Derived Lung Organoids
    Yong Chen, Jianqi Feng, Shanshan Zhao, Le Kha Han, Hongcheng Yang, Ying Lin, Zhili Rong · 2018 · Stem Cells and Development
  36. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease
    Melinda S. Schaller, Mian Chen, Romain Alexandre Colas, Thomas A. Sorrentino, Ann Lazar, S. Marlene Grenon, Jesmond Dalli, Michael S. Conte · 2020 · Journal of the American Heart Association
  37. Lipid Droplets, Phospholipase A2, Arachidonic Acid, and Atherosclerosis
    Miguel Ángel Bermúdez Arias, Marı́a A. Balboa, Jesús Balsinde · 2021 · Biomedicines
  38. The resolvin D2 – GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice
    Matthieu Bardin, Sven‐Christian Pawelzik, Jérémy Lagrange, Ali Mahdi, Hildur H. Arnardottir, Véronique Regnault, Bruno Fève, Patrick J. Lacolley, Jean‐Baptiste Michel, Nathalie Mercier et al. · 2022 · Biochemical Pharmacology
  39. The gut–immune axis during hypertension and cardiovascular diseases
    Evany Dinakis, Joanne A. O’Donnell, Francine Z. Marques · 2024 · Acta Physiologica
  40. Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
    Linn Elisabeth Fosshaug, Romain Alexandre Colas, Anne Kristine Anstensrud, Ida Gregersen, Ståle Haugset Nymo, Ellen Lund Sagen, Annika Elisabet Michelsen, Leif Erik Vinge, Erik Øie, Lars Lysgaard Gullestad et al. · 2019 · EBioMedicine
  41. Metabolic Consequences of Efferocytosis and Its Impact on Atherosclerosis
    Arif Yurdagul · 2021 · Immunometabolism
  42. Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4
    Mingming Liu, Yan Meng, Jinlong He, Huizhen Lv, Zhipeng Chen, Liyuan Peng, Wenbin Cai, Fang Yao, Chen Chen, Lei Shi et al. · 2021 · Circulation Research
  43. Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease
    Vivian Vasconcelos Costa, Michelle A. Sugimoto, Jôsy Hubner, Caio Santos Bonilha, Celso Martins Queiroz‐Junior, Marcela Helena Gonçalves-Pereira, Jianmin Chen, Thomas Gobbetti, Gisele Olinto Libanio Rodrigues, Jordana L Bambirra et al. · 2022 · eLife
  44. Arachidonate 5-lipoxygenase is essential for biosynthesis of specialized pro-resolving mediators and cardiac repair in heart failure
    Ganesh V. Halade, Vasundhara Kain, Shahriare Hossain, Vibhu Parcha, Nita A. Limdi, Pankaj Kumar Arora · 2022 · American Journal of Physiology-Heart and Circulatory Physiology
  45. Roles of Resolvins in Chronic Inflammatory Response
    Chang Liu, Dancai Fan, Qian Lei, Aiping Lü, Xiaojuan He · 2022 · International Journal of Molecular Sciences
  46. Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions—Brief Report
    Emiel P. C. van der Vorst, Manuela Mandl, Madeleine Müller, Carlos Neideck, Yvonne J. F. M. Jansen, Michael Hristov, Selin Gencer, Linsey J. F. Peters, Svenja U. Meiler, Micha Feld et al. · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
  47. Preferential Incorporation of Administered Eicosapentaenoic Acid Into Thin-Cap Atherosclerotic Plaques
    Tomohito Sato, Makoto Horikawa, Shiro Takei, Fumiyoshi Yamazaki, Takashi K. Ito, Takeshi Kondo, Takanobu Sakurai, Tomoaki Kahyo, Koji Ikegami, Shumpei Sato et al. · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
  48. Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis
    Romain Alexandre Colas, Le Thanh Hoang Nhat, Nguyễn Thụy Thương Thương, Esteban A. Gómez, Lucy Ly, Hai Hoang Thanh, Nguyen Thi Hoang, Nguyen Hoan Phu, Guy Edward Thwaites, Jesmond Dalli · 2019 · The FASEB Journal
  49. Exercise-induced specialized proresolving mediators stimulate AMPK phosphorylation to promote mitochondrial respiration in macrophages
    Ernesto Pena Calderin, Jing‐Juan Zheng, Nolan L. Boyd, Lindsey A. McNally, Timothy N. Audam, Pawel Konrad Lorkiewicz, Bradford G. Hill, Jason L. Hellmann · 2022 · Molecular Metabolism
  50. Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation
    Charles Nicholas Serhan, Magnus Bäck, Valerio Chiurchiù, Martin Hersberger, Bettina Mittendorfer, Philip C. Calder, Dan Linetzky Waitzberg, Christian Stoppe, Stanisław Kłęk, Robert G. Martindale et al. · 2024 · The FASEB Journal
  51. Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
    Corneliu Sima, Bruce J. Paster, Thomas E. Van Dyke · 2018 · Critical Reviews in Immunology
  52. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy
    Alexander S. Kim, Michael S. Conte · 2020 · Advanced Drug Delivery Reviews
  53. Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain
    Nini G.L. Callan, Doug Hanes, Ryan D. Bradley · 2020 · Journal of Translational Medicine
  54. Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution
    Umesh Kumar Dhawan, Aarushi Singhal, Manikandan Subramanian · 2021 · Pharmacological Research
  55. Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation
    Chun-Teh Lee, Ruoxing Li, Lisha Zhu, Gena DeVue Tribble, Wenjin Jim Zheng, Brittney Ferguson, Krishna Rao Maddipati, Nikola Angelov, Thomas E. Van Dyke · 2021 · Frontiers in Immunology
  56. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders
    Yong‐Hyun Han, Lee KyeongJin, Abhirup Saha, Juhyeong Han, Haena Choi, Minsoo Noh, Yun‐Hee Lee, Mi‐Ock Lee · 2021 · Biomolecules & Therapeutics
  57. Targeting Angiogenesis via Resolution of Inflammation
    Abigail G. Kelly, Dipak Panigrahy · 2022 · Cold Spring Harbor Perspectives in Medicine
  58. Unified nexus of macrophages and maresins in cardiac reparative mechanisms
    Jeevan Kumar Jadapalli, Ganesh V. Halade · 2018 · The FASEB Journal
  59. Inflammation Resolution in the Cardiovascular System: Arterial Hypertension, Atherosclerosis, and Ischemic Heart Disease
    Azuah Lucrecia Gonzalez, Matthew M Dungan, Charles D Smart, Meena S. Madhur, Amanda C. Doran · 2023 · Antioxidants and Redox Signaling
  60. Race-Based and Sex-Based Differences in Bioactive Lipid Mediators after Myocardial Infarction
    Ganesh V. Halade, Vasundhara Kain, Chrisly Dillion, Timothy Mark Beasley, Tanja Dudenbostel, Suzanne Oparil, Nita A. Limdi · 2020 · ESC Heart Failure
  61. Atherothrombosis and the NLRP3 inflammasome – endogenous mechanisms of inhibition
    Mohan Satish, Devendra K. Agrawal · 2019 · Translational research
  62. Specialized pro-resolving mediators in renal fibrosis
    Eoin Patrick Brennan, Antonino Cacace, Catherine Godson · 2017 · Molecular Aspects of Medicine
  63. Icosapent ethyl in cardiovascular prevention: Resolution of inflammation through the eicosapentaenoic acid - resolvin E1 - ChemR23 axis
    Magnus Bäck · 2023 · Pharmacology & Therapeutics
  64. Targeting formyl peptide receptors to facilitate the resolution of inflammation
    János G. Filep, Meriem Sekheri, Driss El Kebir · 2018 · European Journal of Pharmacology
  65. Immune-based therapies in cardiovascular and metabolic diseases: past, present and future
    Andrew James Murphy, Mark Anthony Febbraio · 2021 · Nature reviews. Immunology
  66. Exercise Promotes Resolution of Acute Inflammation by Catecholamine-Mediated Stimulation of Resolvin D1 Biosynthesis
    Jing‐Juan Zheng, Ernesto Pena Calderin, Bradford G. Hill, Aruni Bhatnagar, Jason L. Hellmann · 2019 · The Journal of Immunology
  67. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling
    Lucía Serrano Díaz del Campo, Raquel Rodrigues‐Díez, Mercedes Salaíces, Ana María Briones, Ana B. García‐Redondo · 2022 · International Journal of Molecular Sciences
  68. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis
    Insha Zahoor, Shailendra Giri · 2020 · Clinical Reviews in Allergy & Immunology
  69. Role of polyunsaturated fatty acids in ischemic stroke – A perspective of specialized pro-resolving mediators
    Zhijuan Miao, Marianne Schultzberg, Xiuzhe Wang, Yuwu Zhao · 2021 · Clinical Nutrition
  70. Inflammatory Basis of Atherosclerosis: Modulation by Sex Hormones
    Suzanne Awni Nasser, Elham A. Afify, Firas H. Kobeissy, Bassam Hamam, Ali Hussein Eid, Mahmoud M. El‐Mas · 2021 · Current Pharmaceutical Design
  71. Circulating Biomarkers Reflecting Destabilization Mechanisms of Coronary Artery Plaques: Are We Looking for the Impossible?
    Marko Kumrić, Josip A. Borovac, Dinko Martinović, Tina Tičinović Kurir, Joško Božić · 2021 · Biomolecules
  72. Unexpected Role of MPO-Oxidized LDLs in Atherosclerosis: In between Inflammation and Its Resolution
    Cecilia Tangeten, Karim Zouaoui Boudjeltia, Cédric Delporte, Pierre Van Antwerpen, Kéziah Korpak · 2022 · Antioxidants
  73. An inflammation resolution–promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction
    Roddy Hiram, Feng Xiong, Patrice Naud, Jiening Xiao, Deanna K. Sosnowski, Ewen Le Quilliec, Arnela Saljic, Issam Abu-Taha, Markus Kamler, Charles-Alexandre LeBlanc et al. · 2023 · Cardiovascular Research
  74. Pro-Resolving Ligands Orchestrate Phagocytosis
    Christa Decker, Sudeshna Sadhu, Gabrielle Fredman · 2021 · Frontiers in Immunology
  75. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis
    Valter Lubrano, Rudina Ndreu, Silvana Balzan · 2023 · International Journal of Molecular Sciences
  76. The diverse roles of macrophages in metabolic inflammation and its resolution
    Aleepta Guha Ray, Oluwatomilayo Odum, Destini Wiseman, Ada Weinstock · 2023 · Frontiers in Cell and Developmental Biology
  77. Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models
    Jiulong Li, Yu Xiao, Yumo Zhang, Silu Li, Minzhi Zhao, Tian Xia, Huan Meng · 2023 · ACS Nano
  78. Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease
    Mary Ellen Walker, Roberta De Matteis, Mauro Perretti, Jesmond Dalli · 2024 · Nature Communications
  79. G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis
    Emiel P. C. van der Vorst, Linsey J. F. Peters, Madeleine Müller, Selin Gencer, Yi Yan, Christian Weber, Yvonne Döring · 2019 · Frontiers in Pharmacology
  80. Biosynthetic metabolomes of cysteinyl‐containing immunoresolvents
    Charlotte Camille Jouvene, Ashley Elizabeth Shay, Mieke Soens, Paul C. Norris, Jesper Z. Haeggström, Charles Nicholas Serhan · 2019 · The FASEB Journal
  81. Omics Approaches Unveiling the Biology of Human Atherosclerotic Plaques
    Xun Wu, Hanrui Zhang · 2024 · American Journal Of Pathology
  82. Pre‐eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma
    Luíza Oliveira Perucci, Talita Adriana Pereira dos Santos, Patrícia Campi Santos, Lívia Cristina Ribeiro Teixeira, Patrícia Nessralla Alpoim, Karina Braga Gomes, Lirlandia Pires Sousa, Luci Maria Sant’Ana Dusse, André Talvani · 2019 · American Journal of Reproductive Immunology
  83. Nanomaterials to Resolve Atherosclerosis
    Erica B. Peters, Melina R. Kibbe · 2020 · ACS Biomaterials Science & Engineering
  84. Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19
    Maria G. Balta, Evangelos Papathanasiou, PANAGIOTIS F. CHRISTOPOULOS · 2021 · Frontiers in Immunology
  85. Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis
    Jamie D. Kraft, Robert Blomgran, Ida Bergström, Matúš Soták, Madison Clark, Alankrita Rani, Meenu Rohini Rajan, Jesmond Dalli, Sofia Nyström, Marianne Quiding‐Järbrink et al. · 2022 · The FASEB Journal
  86. Dynamic Macrophages: Understanding Mechanisms of Activation as Guide to Therapy for Atherosclerotic Vascular Disease
    Julius L. Decano, Masanori Aikawa · 2018 · Frontiers in Cardiovascular Medicine
  87. Sex Differences in the Inflammatory Response: Pharmacological Opportunities for Therapeutics for Coronary Artery Disease
    Asad Shabbir, Krishnaraj Sinhji Rathod, Rayomand S. Khambata, Amrita Ahluwalia · 2020 · The Annual Review of Pharmacology and Toxicology
  88. Lipids in Liver Failure Syndromes: A Focus on Eicosanoids, Specialized Pro-Resolving Lipid Mediators and Lysophospholipids
    Florent Artru, Mark J.W. McPhail, Evangelos Triantafyllou, Francesca Maria Trovato · 2022 · Frontiers in Immunology
  89. Molecular Pharmacology of Inflammation Resolution in Atherosclerosis
    Stanislav Nikolaevich Kotlyarov, Анна Анатольевна Котлярова · 2022 · International Journal of Molecular Sciences
  90. Omega-3 and cardiovascular prevention – Is this still a choice?
    Massimiliano Ruscica, Cesare Riccardo Sirtori, Stefano Carugo, Philip C. Calder, Alberto Corsini · 2022 · Pharmacological Research
  91. Tackling inflammation in atherosclerosis: Are we there yet and what lies beyond?
    Purbasha Bhattacharya, Ragulan Kanagasooriyan, Manikandan Subramanian · 2022 · Current Opinion in Pharmacology
  92. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
    Mengmeng Zhao, Zihui Zheng, Zheng Yin, Jishou Zhang, Juan‐Juan Qin, Jun Wan, Menglong Wang · 2023 · Pharmacological Research
  93. 13‐Series resolvins mediate the leukocyte‐platelet actions of atorvastatin and pravastatin in inflammatory arthritis
    Mary Ellen Walker, Patricia R. Souza, Romain Alexandre Colas, Jesmond Dalli · 2017 · The FASEB Journal
  94. Lipid mediators in neutrophil biology: inflammation, resolution and beyond
    Anita Ghodsi, Andrés Hidalgo, Stephania Libreros · 2024 · Current Opinion in Hematology
  95. Resolvin D1 blocks H2O2-mediated inhibitory crosstalk between SHP2 and PP2A and suppresses endothelial-monocyte interactions
    Rima Chattopadhyay, Arul Murugan Mani, Nikhlesh Kumar Singh, Gadiparthi N. Rao · 2018 · Free Radical Biology and Medicine
  96. Dietary Control of Inflammation and Resolution
    B. Sears, A. Saha · 2021 · Frontiers in Nutrition
  97. Extrinsic and intrinsic modulators of inflammation-resolution signaling in heart failure
    Archana Rao, Akul Gupta, Vasundhara Kain, Ganesh V. Halade · 2023 · American Journal of Physiology-Heart and Circulatory Physiology
  98. CD36 Shunts Eicosanoid Metabolism to Repress CD14 Licensed Interleukin-1β Release and Inflammation
    Karina Furlani Zoccal, Luiz Gustavo Gardinassi, Carlos A. Sorgi, Alyne Fávero Galvão Meirelles, Karla de Castro Figueiredo Bordon, Isaías Glezer, Palmira Cupo, Alessandra Kimie Matsuno, Valdes Roberto Bóllela, Eliane Candiani Arantes et al. · 2018 · Frontiers in Immunology
  99. Integrative omics analyses uncover the mechanism underlying the immunotoxicity of perfluorooctanesulfonate in human lymphocytes
    Rong Li, Chao Guo, Xiao Lin, Ting‐Fung Chan, Keng Po Lai, Jian Chen · 2020 · Chemosphere
  100. Specialized pro-resolving mediators in diabetes: novel therapeutic strategies
    Eoin Patrick Brennan, Muthukumar Mohan, Darrell C. Andrews, Madhura Bose, Phillip Kantharidis · 2019 · Clinical Science